Last Price
20.30
Today's Change
+4.71 (30.21%)
Day's Change
15.48 - 20.93
Trading Volume
1,057,188
Overview
Market Cap
301 Million
Shares Outstanding
14 Million
Avg Volume
251,312
Avg Price (50 Days)
45.41
Avg Price (200 Days)
38.82
PE Ratio
-4.96
EPS
-4.09
Earnings Announcement
17-Mar-2025
Previous Close
15.59
Open
15.48
Day's Range
15.48 - 20.93
Year Range
12.49 - 74.49
Trading Volume
1,059,648
Price Change Highlight
1 Day Change
30.21%
5 Day Change
-8.72%
1 Month Change
-58.19%
3 Month Change
-41.90%
6 Month Change
-35.54%
Ytd Change
2.16%
1 Year Change
43.36%
3 Year Change
-80.92%
5 Year Change
-76.06%
10 Year Change
-87.39%
Max Change
-91.51%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
1
CEO Morning Brief
2
CEO Morning Brief
Starbucks Shrank Retail Staff 8% Despite Hundreds of New Stores
3
4
CEO Morning Brief
Bitcoin Climbs Closer to US$100,000 on Trump’s Support for Crypto
5
CEO Morning Brief
Starbucks Said to Consider Selling Stake in Chinese Business
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
